The valuable attempts for detecting and targeting the important genes in gastroenteropancreatic neuroendocrine tumors (GEP-NETs)114, prostate cancer115, etc., provided new inhibitors for Aurora genes (i.e., AURKA and AURKB) like ZM447439 and Hesperadin ultimately. This evidence concerns the gene AURKB and digestive system neuroendocrine tumor, grade 1/2.